Do you know that Guizhou Bailing has strong comprehensive strength?

You can find this on the Internet. There is no doubt that Guizhou Bailing, as a national leading Miao medicine enterprise, has strong comprehensive strength, whether it is R&D, production strength or marketing ability. Not long ago, Guizhou Bailing won the title of "Top 30 Chinese Medicine Enterprises in China Top 100 Pharmaceutical Industry" again, which has great credibility and authority in the industry.

In terms of research and development, Guizhou Bailing is based on traditional Chinese medicine/ethnic medicine, with original new drugs such as chemical drugs and biological drugs as its wings, aiming at the four major directions of malignant tumors, metabolic diseases, infectious diseases and clinical blank areas, keeping up with the forefront of international scientific research, and continuing to develop new drugs to enhance the company's product reserves and research and development strength. At present, the company has undertaken 7 national major scientific and technological projects such as "major new drug creation", more than 50 invention patents 17 international patents17.

I also checked, and there is data to prove that Guizhou Bailing currently has an OTC sales team of 5,000 people, and has set up 63 offices and more than 300 business contact points in prefecture-level cities across the country. Its sales network covers 32 provinces, municipalities and autonomous regions in China, achieving more than 3,200 first-class and second-class dealers in each province, more than 4,500 hospitals with second-class and above hospital customers, and three-class hospitals 1600, achieving a total of more than 400 retail terminals.